NextCure
NXTC
92 hedge funds and large institutions have $180M invested in NextCure in 2021 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 24 increasing their positions, 33 reducing their positions, and 12 closing their positions.
75% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 12
13% more capital invested
Capital invested by funds: $158M → $180M (+$21.2M)
11% more funds holding
Funds holding: 83 → 92 (+9)
1.02% more ownership
Funds ownership: 4.4% → 5.42% (+1%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
27% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 33
44% less call options, than puts
Call options by funds: $1.73M | Put options by funds: $3.08M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$32.2M |
| 2 |
BlackRock
New York
|
+$7.77M |
| 3 |
SG Americas Securities
New York
|
+$3.86M |
| 4 |
CLOS
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
|
+$3.36M |
| 5 |
LOAMS
Lombard Odier Asset Management (Switzerland)
Petit-Lancy,
Switzerland
|
+$3.36M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$14.5M |
| 2 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$5.9M |
| 3 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$1.42M |
| 4 |
Man Group
London,
United Kingdom
|
-$1.17M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
-$917K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WC
101
Wexford Capital
West Palm Beach,
Florida
| – | -$43K | -329 | Closed |
|
102
Federated Hermes
Pittsburgh,
Pennsylvania
| – | -$34K | -257 | Closed |
|
103
Russell Investments Group
London,
United Kingdom
| – | -$25K | -196 | Closed |
|
NXTC Hedge Fund Activity: Q1 2021 in Review
92 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in NextCure (NXTC) for Q1 2021, worth a combined $180M — up 13% from $158M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new NXTC positions and 12 closed out — a net gain of 9 holders — while 24 added to existing stakes and 33 trimmed.
The largest buyer was Sofinnova Investments, opening a new position worth an estimated $32.2M. The largest seller was Morgan Stanley, cutting an estimated $14.5M.
- 92 institutional investors held NextCure (NXTC) as of Q1 2021, up from 83 in Q4 2020.
- Funds reported $180M of NextCure stock for Q1 2021, up 13% quarter-over-quarter.
- 21 funds opened new NextCure positions in Q1 2021 and 12 closed out, a net change of +9 holders.
- The largest NextCure buyer in Q1 2021 was Sofinnova Investments, an estimated $32.2M added.
- The largest NextCure seller in Q1 2021 was Morgan Stanley, an estimated $14.5M sold.
Based on aggregated 13F filings for Q1 2021.